Reactivity to tumor antigens is important for tumor-infiltrating lymphocyte therapy, study shows

Published Date: 09 May 2025

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings, published in Nature Cancer, may ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nuclear missile workers are contracting cancer: They blame the bases

2.

Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants

3.

New analysis helps discern benign from malignant thyroid growths

4.

MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information

5.

Even a few mutated cells can significantly impact how blood cancers develop, study finds


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot